Jove
Visualize
お問い合わせ
JoVE
x logofacebook logolinkedin logoyoutube logo
JoVEについて
概要リーダーシップブログJoVEヘルプセンター
著者向け
出版プロセス編集委員会範囲と方針査読よくある質問投稿
図書館員向け
推薦の声購読アクセスリソース図書館諮問委員会よくある質問
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experimentsアーカイブ
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教員リソースセンター教員サイト
利用規約
プライバシーポリシー
ポリシー

関連する概念動画

Phase II Reactions: Glucuronidation01:24

Phase II Reactions: Glucuronidation

767
Glucuronidation, a pivotal phase II biotransformation process, involves the coupling of glucuronic acid to a drug or xenobiotic. Given its widespread occurrence and critical role in drug metabolism, it's considered the most crucial phase II reaction. It enhances the water solubility of substances, aiding their expulsion from the body. The driving force behind these reactions is a group of enzymes known as UDP-glucuronosyltransferases (UGTs). UGTs facilitate the transfer of a glucuronic acid...
767
Hepatic Drug Excretion: Influencing Factors01:16

Hepatic Drug Excretion: Influencing Factors

214
The biliary system of the liver, crucial for bile secretion and drug excretion, comprises intrahepatic bile ducts that merge to form the common hepatic duct. This duct, carrying hepatic bile, combines with the cystic duct, draining the gallbladder and forming the common bile duct, which empties into the duodenum. Bile, produced by hepatic cells lining the bile canaliculi, is composed primarily of water, bile salts, pigments, electrolytes, and lesser amounts of cholesterol and fatty acids. Bile...
214
Liver Regeneration01:24

Liver Regeneration

3.4K
The liver is an important organ in vertebrates that plays an essential role in metabolism. It is also responsible for storing and redistributing nutrients such as carbohydrates, fats, and vitamins in the body. Additionally, the liver releases bile salts which are critical for digesting food and eliminating toxic metabolites from the body.
Cells of Liver
The liver comprises four major types of cells— hepatocytes, stellate, Kupffer, and sinusoidal endothelial cells. The hepatocytes are...
3.4K
Drugs for Peptic Ulcer Disease: Sucralfate as Mucosal Protective Agents01:24

Drugs for Peptic Ulcer Disease: Sucralfate as Mucosal Protective Agents

684
In the intricate landscape of the gastric lumen, excessive acid secretion disrupts the natural defense mechanisms, weakening the mucus-bicarbonate barrier. This vulnerability allows pepsin to infiltrate epithelial cells, digesting mucosal proteins and triggering erosion, leading to ulcer formation.
In this scenario, mucosal protective agents like sucralfate play an essential role. Sucralfate, a complex of sulfated sucrose and aluminum hydroxide, demonstrates its usefulness in acidic conditions,...
684
Drug Metabolism: Phase II Reactions01:14

Drug Metabolism: Phase II Reactions

4.1K
Phase II reactions are essential for the detoxification and elimination of drugs from the body. These reactions involve the conjugation of parent drugs or their phase I metabolites with endogenous molecules, resulting in more hydrophilic drug conjugates. The primary conjugation reactions in this phase are sulfation and glucuronidation. Both sulfation and glucuronidation typically produce biologically inactive metabolites. However, in some cases involving prodrugs, active metabolites may be...
4.1K
Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

865
Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
865

こちらも読む

関連記事

共著者、ジャーナル、引用グラフによってこの研究に関連する記事。

並び替え
Same author

Clinical Characteristics of Metabolic Dysfunction Steatotic Liver Disease in Asian-American Patients with Chronic Hepatitis B.

Journal of immigrant and minority health·2026
Same author

Comparison of Kidney Allograft Outcomes in Simultaneous Liver-Kidney Versus Kidney After Liver Transplantation Since the Safety Net Era.

Clinical transplantation·2025
Same author

Drug-Induced Liver Injury Secondary to Radionuclide Therapy With Lutetium-177 Vipivotide Tetraxetan in a Patient With Metastatic Castrate-Resistant Prostate Cancer.

ACG case reports journal·2025
Same author

Metabolic Dysfunction-Associated Steatotic Liver Disease in Pregnancy.

Obstetrical & gynecological survey·2025
Same author

A Perfect MASH Comparing Resmetirom and GLP-1 Agonists for Metabolic-Associated Steatohepatitis: What Does the Current Evidence Suggest?

Journal of clinical gastroenterology·2025
Same author

MASLD-F Algorithm to the Rescue: Improving Noninvasive Diagnosis of Hepatic Fibrosis in Patients With Severe Obesity.

Journal of clinical gastroenterology·2025
Same journal

Post-extubation pneumothorax following bougie-assisted endotracheal tube exchange.

BMJ case reports·2026
Same journal

Cardiac tamponade secondary to hypothyroidism.

BMJ case reports·2026
Same journal

Unmasking a rare contrast reaction: acute non-cardiogenic pulmonary oedema after iohexol injection.

BMJ case reports·2026
Same journal

Water gonioscopy-assisted transluminaltrabeculotomy.

BMJ case reports·2026
Same journal

<i>Clostridioides difficile</i> osteomyelitis presenting as a Brodie's abscess of the tibia.

BMJ case reports·2026
Same journal

Steroid refractory rapidly progressing organising pneumonia.

BMJ case reports·2026
関連記事をすべて見る

関連する実験動画

Updated: Sep 9, 2025

Cell Type-specific Gene Expression Profiling in the Mouse Liver
10:06

Cell Type-specific Gene Expression Profiling in the Mouse Liver

Published on: September 17, 2019

7.8K

フェブクソスタットによる肝細胞損傷

Joanne Lin1,2, David Braxton3, Tse-Ling Fong4

  • 1Hoag Digestive Health Institute, Hoag Memorial Hospital Presbyterian, Newport Beach, California, USA joanne.lin@ucsf.edu.

BMJ case reports
|August 31, 2025
PubMed
まとめ
この要約は機械生成です。

このケーススタディは,痛風患者のフェブクソスタット誘発性肝損傷の希少な事例を強調しています. 肝機能のモニタリングはフェブクソスタットを使用している人にとって非常に重要です.

キーワード:
薬と薬剤肝臓疾患

さらに関連する動画

Bile Duct Ligation in Mice: Induction of Inflammatory Liver Injury and Fibrosis by Obstructive Cholestasis
08:56

Bile Duct Ligation in Mice: Induction of Inflammatory Liver Injury and Fibrosis by Obstructive Cholestasis

Published on: February 10, 2015

52.8K
Identification of the Source of Secreted Proteins in the Kidney by Brefeldin A Injection
10:15

Identification of the Source of Secreted Proteins in the Kidney by Brefeldin A Injection

Published on: November 10, 2021

1.9K

関連する実験動画

Last Updated: Sep 9, 2025

Cell Type-specific Gene Expression Profiling in the Mouse Liver
10:06

Cell Type-specific Gene Expression Profiling in the Mouse Liver

Published on: September 17, 2019

7.8K
Bile Duct Ligation in Mice: Induction of Inflammatory Liver Injury and Fibrosis by Obstructive Cholestasis
08:56

Bile Duct Ligation in Mice: Induction of Inflammatory Liver Injury and Fibrosis by Obstructive Cholestasis

Published on: February 10, 2015

52.8K
Identification of the Source of Secreted Proteins in the Kidney by Brefeldin A Injection
10:15

Identification of the Source of Secreted Proteins in the Kidney by Brefeldin A Injection

Published on: November 10, 2021

1.9K

科学分野:

  • ヘパトロジー
  • 薬理学について

背景:

  • フェブクソスタットは,痛風と高尿血症に対するキサンチン酸化酵素阻害剤です.
  • 一般的には安全ですが,薬剤による肝損傷 (DILI) の稀な症例はフェブクソスタットに関連しています.

研究 の 目的:

  • フェブクソスタット投与開始後の肝損傷の報告
  • 肝臓機能のモニタリングの重要性を強調する

主な方法:

  • 50代後半の男性患者の症例報告です
  • 臨床表現,検査結果,肝臓生検の結果を分析した.
  • フェブクソスタット投与の中止と,その後のプレドニゾンの治療に対する反応が記録された.

主要な成果:

  • フェブクソスタットに切り替えると 疲労,吐き気,黄,およびアミノトランスフェラスの値上昇が起こりました.
  • 肝臓生検で 肝細胞損傷が確認されました
  • 肝臓の検査は,治療を中止して1ヶ月後に改善された.

結論:

  • このケースはフェブクソスタットによる肝損傷の理解に寄与する.
  • フェブクソスタットDILIの臨床および組織学的表象は変化する可能性があります.
  • 肝臓検査の警戒はフェブクソスタットを処方された患者にとって不可欠です.